TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17151157

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 15457336

Group type: EXPERIMENTAL
Intervention: Auditory stimulation device
Number of subjects: 6

Group type: COMPARATOR
Intervention: Prior reports on rhythmic auditory facilitation
Number of subjects: 6
Study: 10933353

Group type: EXPERIMENTAL
Intervention: Diet plus 20 mg/day simvastatin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Diet
Number of subjects: 16
Study: 8825266

Group type: EXPERIMENTAL
Intervention: Madopar HBS
Number of subjects: 134

Group type: COMPARATOR
Intervention: Standard Madopar
Number of subjects: 134
Study: 1317048

Group type: EXPERIMENTAL
Intervention: Acute exposure to alcohol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute exposure to cocaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Withdrawal from alcohol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thyroid and prolactin regulation measures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed index of HPA axis dysfunction
Number of subjects: 0
Study: 3956105

Group type: EXPERIMENTAL
Intervention: Breathlessness scaling using visual analogue scaling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnitude estimation of breathlessness
Number of subjects: 0
Study: 29304734

Group type: EXPERIMENTAL
Intervention: Pre-notification postcard
Number of subjects: 28134

Group type: EXPERIMENTAL
Intervention: Longer questionnaire
Number of subjects: 28134

Group type: EXPERIMENTAL
Intervention: Reminder
Number of subjects: 28134
Study: 27271809

Group type: EXPERIMENTAL
Intervention: Cluster 1 (high levels of overall QOL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster 2 (medium levels of overall QOL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster 3 (medium levels of overall QOL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster 4 (low levels of overall QOL)
Number of subjects: 0
Study: 25047308

Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic surgery (SIL-V)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Conventional laparoscopic varicocelectomy (CL-V)
Number of subjects: 69
Study: 22989894

Group type: EXPERIMENTAL
Intervention: Smartphone questionnaire
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pen-and-paper questionnaire
Number of subjects: 120
Study: 20120420

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser treatment
Number of subjects: 100
Study: 18407355

Group type: EXPERIMENTAL
Intervention: 2% alcoholic chlorhexidine
Number of subjects: 2146

Group type: COMPARATOR
Intervention: 10% aqueous povidone-iodine
Number of subjects: 2146
Study: 15653255

Group type: EXPERIMENTAL
Intervention: FAQ checklist mailed to patients after 1, 4, and 10 months post-discharge for CAD.
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no checklist).
Number of subjects: 105
Study: 11831346

Group type: EXPERIMENTAL
Intervention: Passive jaw motion device therapy (Therabite)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Wooden tongue depressors therapy (WTD)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 10362007

Group type: EXPERIMENTAL
Intervention: Exercise training (n = 23), combined endurance and strength training at 75% to 80% intensity, 3 times/week for 6 months.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (n = 26), nonexercise.
Number of subjects: 49
Study: 7741566

Group type: EXPERIMENTAL
Intervention: Metered dose inhaler (MDI) with a valved holding chamber
Number of subjects: 111

Group type: COMPARATOR
Intervention: Nebuliser driven by air
Number of subjects: 111
Study: 2048819

Group type: EXPERIMENTAL
Intervention: Budesonide, 800 micrograms twice a day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7002706

Group type: EXPERIMENTAL
Intervention: Loperamide (4.6 mg, 2.3 capsules)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Codeine (103.5 mg, 2.3 capsules)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diphenoxylate (12.5 mg, 2.5 capsules)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study: 31998949

Group type: EXPERIMENTAL
Intervention: Surface perturbation treadmill training integrated into usual multimodal exercise-based balance training
Number of subjects: 506

Group type: COMPARATOR
Intervention: Usual multimodal exercise-based balance training alone
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Surface perturbation treadmill training
Number of subjects: 506
Study: 31839091

Group type: EXPERIMENTAL
Intervention: Probiotic (lactobacillus rhamnosus) with ORS
Number of subjects: 80

Group type: COMPARATOR
Intervention: ORS only
Number of subjects: 80
Study: 28746324

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Combined therapy (CBT and pharmacotherapy)
Number of subjects: 135
Study: 25782662

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.375%
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75%
Number of subjects: 46

Group type: COMPARATOR
Intervention: Ropivacaine 0.375% vs Ropivacaine 0.75%
Number of subjects: 46
Study: 23894842

Group type: EXPERIMENTAL
Intervention: Clinical nursing pathway (CNP) group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine nursing group (control group)
Number of subjects: 64
Study: 21259026

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (A: 30 min, cycle ergometer, 75% of VO(2) peak)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Resistance exercise (R: 6 exercises, 3 sets, 20 repetitions, 50% of 1 RM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Concurrent exercise (AR: A + R)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (C: 30 min of rest)
Number of subjects: 20
Study: 19275979

Group type: EXPERIMENTAL
Intervention: Internet administration of the Kansas City Cardiomyopathy Questionnaire (KCCQ)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Internet administration of the Minnesota Living with Heart Failure Questionnaire (MLHFQ)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Internet administration of the Self-Care Heart Failure Index (SCHFI)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Pen-and-paper administration of the Kansas City Cardiomyopathy Questionnaire (KCCQ)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Pen-and-paper administration of the Minnesota Living with Heart Failure Questionnaire (MLHFQ)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Pen-and-paper administration of the Self-Care Heart Failure Index (SCHFI)
Number of subjects: 58
Study: 17673936

Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 59
Study: 14767287

Group type: COMPARATOR
Intervention: EBRT alone (group 1)
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: EBRT preceded by 3 months of AS (group 2)
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Neoadjuvant, concomitant and adjuvant AS for a total of 10 months (group 3)
Number of subjects: 481

Group type: COMPARATOR
Intervention: Neoadjuvant and concomitant AS (total 5 months)
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Neoadjuvant, concomitant and short course adjuvant AS (total 10 months)
Number of subjects: 481
Study: 11332151

Group type: EXPERIMENTAL
Intervention: CEF14 (chemotherapy regimen delivered every two weeks)
Number of subjects: 247

Group type: COMPARATOR
Intervention: CEF21 (chemotherapy regimen delivered every three weeks)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Hypofractionation (RT applied at 2.3 Gy per fraction)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Concomitant administration of RT and CT
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Age <= 55 years
Number of subjects: 247

Group type: COMPARATOR
Intervention: Conventional RT
Number of subjects: 247

Group type: COMPARATOR
Intervention: WBC toxicity (none)
Number of subjects: 247
Study: 8995997

Group type: EXPERIMENTAL
Intervention: Behavioral counseling to reduce ETS exposure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-monitoring control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual medical care control
Number of subjects: 0
Study: 8424300

Group type: EXPERIMENTAL
Intervention: Clonidine (0.3 mg orally)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lignocaine (1.5 mg.kg‐1 prior to induction)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no intervention specified)
Number of subjects: 60
Study: 3301160

Group type: EXPERIMENTAL
Intervention: Insulatard
Number of subjects: 17

Group type: COMPARATOR
Intervention: Lentard
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Mixtard
Number of subjects: 17
Study: 29334900

Group type: EXPERIMENTAL
Intervention: RaDIANT multicomponent education and quality improvement intervention
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: RaDIANT intervention activities
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: RaDIANT intervention components
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: RaDIANT intervention
Number of subjects: 67
Study: 28591942

Group type: EXPERIMENTAL
Intervention: Sialidase inhibitor N‐Acetyl‐2, 3‐dehydro‐2‐deoxyneuraminic acid (DANA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 24491287

Group type: EXPERIMENTAL
Intervention: Lateral ileostomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Percutaneous ileostomy by exclusion probe
Number of subjects: 0
Study: 22383336

Group type: EXPERIMENTAL
Intervention: Pasireotide LAR 40 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pasireotide LAR 60 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pasireotide LAR (both doses)
Number of subjects: 12
Study: 20542295

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri (DSM 17938)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 18801190

Group type: EXPERIMENTAL
Intervention: Standardized hypnosis treatment with ten consecutive therapeutic sessions once a week, each lasting about 30 minutes, focusing on ego-strengthening, relaxation, releasing muscular tension, and increasing self-efficacy.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no treatment during initial phase).
Number of subjects: 16
Study: 15630590

Group type: EXPERIMENTAL
Intervention: 0.65 g/kg alcohol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Visual degradation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Alcohol plus visual degradation
Number of subjects: 16

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 16
Study: 12717603

Group type: EXPERIMENTAL
Intervention: Subcutaneous specific immunotherapy with Der p/Der f
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 10493672

Group type: EXPERIMENTAL
Intervention: SLE sera absorbed with bacterial DNA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NHS sera absorbed with bacterial DNA
Number of subjects: 0
Study: 7600829

Group type: EXPERIMENTAL
Intervention: Antiseptic hand washing with 4% chlorhexidine and alcohol
Number of subjects: 43

Group type: COMPARATOR
Intervention: Casual donning of nonsterile gloves over unwashed hands
Number of subjects: 43

Group type: COMPARATOR
Intervention: Casual donning of nonsterile gloves over washed hands
Number of subjects: 43

Group type: COMPARATOR
Intervention: Aseptic donning technique with or without prior antiseptic hand washing
Number of subjects: 43
Study: 2018441

Group type: EXPERIMENTAL
Intervention: Stanozolol 5 mg twice daily for 6 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo tablet twice daily for 6 months
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (Stanozolol and Placebo)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Stanozolol
Number of subjects: 60
Study: 7114130

Group type: EXPERIMENTAL
Intervention: Progesterone implants (6 pellets of 100 mg each)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Injectable placebo
Number of subjects: 84

Group type: COMPARATOR
Intervention: TCu 200 intrauterine contraceptive device
Number of subjects: 84
Study: 31680183

Group type: EXPERIMENTAL
Intervention: Group A (horizontal placement on suprahyoid and infrahyoid muscles)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Group B (horizontal on suprahyoid, vertical on infrahyoid)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Group C (vertical placement above hyoid and cricoid)
Number of subjects: 31
Study: 30531440

Group type: EXPERIMENTAL
Intervention: Midwife-based counseling education program (4 sessions, 70 minutes each, at 10-day intervals)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 52
Study: 28237126

Group type: EXPERIMENTAL
Intervention: White matter lesions (WMLs) present
Number of subjects: 262

Group type: COMPARATOR
Intervention: No white matter lesions (WMLs)
Number of subjects: 262
Study: 26088940

Group type: EXPERIMENTAL
Intervention: Chronic Pain Management Program (8-week online intervention)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Wait-list comparison (8-week delay)
Number of subjects: 92
Study: 24706589

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 0
Study: 22559239

Group type: EXPERIMENTAL
Intervention: Laparoscopic LLS
Number of subjects: 110

Group type: COMPARATOR
Intervention: Open LLS
Number of subjects: 110
Study: 19603240

Group type: EXPERIMENTAL
Intervention: GEB-guided technique
Number of subjects: 75

Group type: COMPARATOR
Intervention: IT-guided technique
Number of subjects: 75
Study: 17304123

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sitting extended position
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Supine to standing position change
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: L5/S1 level
Number of subjects: 32
Study: 15385363

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 32
Study: 11419556

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 9738562

Group type: EXPERIMENTAL
Intervention: Raltitrexed (3 mg/m2) once every 3 weeks
Number of subjects: 495

Group type: COMPARATOR
Intervention: 5-FU (400 mg/m2) plus LV (200 mg/m2) daily for 5 days every 4 weeks
Number of subjects: 495
Study: 7972979

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg b.i.d. (sustained release tablets)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 153
Study: 2743632

Group type: EXPERIMENTAL
Intervention: Daily observed prophylaxis (DOP) and education
Number of subjects: 42

Group type: COMPARATOR
Intervention: Self‐administered anti‐tuberculous prophylaxis (SAP) and education
Number of subjects: 42
Study: 4851604

Group type: EXPERIMENTAL
Intervention: Amiloride 10 mg daily in the postoperative period
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31755620

Group type: EXPERIMENTAL
Intervention: Rapid Maxillary Expansion (RME)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Slow Maxillary Expansion (SME)
Number of subjects: 29
Study: 29459184

Group type: EXPERIMENTAL
Intervention: Urinary cadmium at 10 years (highest tertile: 0.30-2.6 μg/L)
Number of subjects: 1498

Group type: EXPERIMENTAL
Intervention: Urinary cadmium at 5 years
Number of subjects: 1498

Group type: EXPERIMENTAL
Intervention: Urinary cadmium at 10 years (highest tertile)
Number of subjects: 1498

Group type: EXPERIMENTAL
Intervention: Prenatal cadmium exposure
Number of subjects: 1498
Study: 27116347

Group type: EXPERIMENTAL
Intervention: Flywheel leg curl
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nordic hamstring
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Russian belt
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Conic‐pulley exercise
Number of subjects: 36
Study: 25400467

Group type: EXPERIMENTAL
Intervention: Needle‐free incision suture closure
Number of subjects: 223

Group type: COMPARATOR
Intervention: Butterfly bandage
Number of subjects: 223

Group type: COMPARATOR
Intervention: Traditional secondary suturing technique
Number of subjects: 223
Study: 22698919

Group type: EXPERIMENTAL
Intervention: 3.0 pmol/kg/min human BNP-32 administered as a continuous infusion during 4 h
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 20555287

Group type: EXPERIMENTAL
Intervention: Exercise group (60 women)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (61 women)
Number of subjects: 121
Study: 18662627

Group type: EXPERIMENTAL
Intervention: Fast-track group (FTG) with remifentanil and spinal analgesia (low-dose morphine and clonidine)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (CG) with sufentanil without spinal analgesia
Number of subjects: 83
Study: 16649874

Group type: EXPERIMENTAL
Intervention: Tobacco use intervention (smoking cessation, smokeless tobacco use cessation, or prevention)
Number of subjects: 33215

Group type: COMPARATOR
Intervention: Health education control condition
Number of subjects: 33215

Group type: EXPERIMENTAL
Intervention: Smoking prevention program
Number of subjects: 33215
Study: 12514274

Group type: EXPERIMENTAL
Intervention: Pork meat cooked at 70 degrees C
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pork meat cooked at 95 degrees C
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pork meat cooked at 120 degrees C
Number of subjects: 21
Study: 11225941

Group type: EXPERIMENTAL
Intervention: Fractally coated electrode (iridium)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Uncoated electrode
Number of subjects: 30
Study: 8727433

Group type: EXPERIMENTAL
Intervention: CT management (G1)
Number of subjects: 103

Group type: COMPARATOR
Intervention: BP management (G2)
Number of subjects: 103
Study: 1869800

Group type: EXPERIMENTAL
Intervention: 1500 mg aspirin per day for two days
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 6626478

Group type: EXPERIMENTAL
Intervention: 100 ppm toluene for 6.5 hours
Number of subjects: 42

Group type: COMPARATOR
Intervention: 0 ppm toluene for 6.5 hours
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Standardisation of HA and O‐Cr concentrations
Number of subjects: 42
Study: 30204520

Group type: EXPERIMENTAL
Intervention: Plyometric training and change‐of‐direction (COD) exercises
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Plyometric training and COD exercises
Number of subjects: 31
Study: 29183698

Group type: EXPERIMENTAL
Intervention: Customized porous titanium implants
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Customized PEEK implants
Number of subjects: 10
Study: 26948292

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 24566753

Group type: EXPERIMENTAL
Intervention: High-repetition resistance training (3 d·wk for 6 months)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 74
Study: 23106962

Group type: EXPERIMENTAL
Intervention: Criterion-based clinical audit (CBCA) applied by auditors at 8 sites in Mali and Senegal
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: Criterion-based clinical audit (CBCA) conducted at 32 hospitals
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: Adjusted CBCA scores
Number of subjects: 818
Study: 20166160

Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL) treatment on one side of the face, four treatments at 3- to 4-week intervals.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control side (untreated side of the face).
Number of subjects: 24
Study: 17170356

Group type: EXPERIMENTAL
Intervention: Carotid Stenosis Index (CSI) estimate of carotid bulb size
Number of subjects: 268

Group type: COMPARATOR
Intervention: Actual carotid bulb measurement
Number of subjects: 268
Study: 16314784

Group type: COMPARATOR
Intervention: Tacrolimus plus low-dose short-term steroids
Number of subjects: 40
Study: 11923325

Group type: EXPERIMENTAL
Intervention: 100 mg of ramoplanin
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 400 mg of ramoplanin
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Ramoplanin (all doses)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Ramoplanin (all doses) with antibiotics against anaerobic organisms
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Ramoplanin (all doses) avoiding antibiotics against anaerobic organisms
Number of subjects: 3
Study: 12712699

Group type: EXPERIMENTAL
Intervention: High energy breakfast
Number of subjects: 151

Group type: COMPARATOR
Intervention: Low energy breakfast
Number of subjects: 151
Study: 8778647

Group type: EXPERIMENTAL
Intervention: EHDP (etidronate disodium)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control (untreated group)
Number of subjects: 77
Study: 1977079

Group type: EXPERIMENTAL
Intervention: Standard-treatment group (zidovudine 250 mg every four hours)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Low-dose group (zidovudine 200 mg every four hours for four weeks, then 100 mg every four hours)
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Standard-treatment group
Number of subjects: 524

Group type: COMPARATOR
Intervention: Low-dose group
Number of subjects: 524
Study: 513673

Group type: EXPERIMENTAL
Intervention: Group 1 (planning and assessment training)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group 2 (no planning and assessment training)
Number of subjects: 0
Study: 30315130

Group type: EXPERIMENTAL
Intervention: 1% Cyclopentolate Hydrochloride for cycloplegic autorefraction
Number of subjects: 1626

Group type: EXPERIMENTAL
Intervention: Visual acuity assessment with spectacles if worn
Number of subjects: 1626
Study: 28697497

Group type: EXPERIMENTAL
Intervention: Intravitreal injections of aflibercept (IVA) 2.0 mg every 2 months after 3 initial monthly doses
Number of subjects: 50
Study: 26448315

Group type: EXPERIMENTAL
Intervention: 4‐0 polypropylene running sutures
Number of subjects: 10

Group type: COMPARATOR
Intervention: 1/4 Steri‐Strip films
Number of subjects: 10